Syapse, a San Francisco, CA-based developer of precision medicine solutions, raised $30m in Series D financing.
Participants included existing investors Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Scientifics, and Social Capital, as well as new investors Amgen Ventures, Medidata Solutions, Merck Global Health Innovation Fund, and Roche Venture Fund.
The company intends to use the funds to expand operations and bring its solutions to more providers and their cancer patients.
Led by Ken Tarkoff, CEO, Syapse provides an oncology software platform that enables oncologists to practice precision medicine consistently across large health systems. The Syapse Data Sharing Network enables physicians to view treatments and outcomes for patients across the country and use this information to improve treatment decisions for their own patients.
Customers include Intermountain Healthcare, Providence St. Joseph Health, Henry Ford Health System, Aurora Health Care, Catholic Health Initiatives and Dignity Health.